Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Long-Term Deferred Tax (2017 - 2024)

Dianthus Therapeutics (DNTH) has 2 years of Long-Term Deferred Tax data on record, last reported at $21.7 million in Q4 2024.

  • For Q4 2024, Long-Term Deferred Tax changed N/A year-over-year to $21.7 million; the TTM value through Dec 2024 reached $21.7 million, changed N/A, while the annual FY2024 figure was $21.7 million, N/A changed from the prior year.
  • Long-Term Deferred Tax reached $21.7 million in Q4 2024 per DNTH's latest filing, up from $12.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $21.7 million in Q4 2024 and bottomed at $21.7 million in Q4 2024.